Avisa Diagnostics Inc.
OTC: FOGCF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- David S. Joseph
- Employees
- 3
- Headquarters
- Santa Fe, United States
- IPO year
- 2021
- Market cap
- $97.2K
- Website
- https://www.avisadx.com
Loading FOGCF…
Loading profile data…Frequently asked questions about FOGCF
What does Avisa Diagnostics Inc. (FOGCF) do?
Avisa Diagnostics Inc. is a medical device company currently in its clinical development phase. The company is advancing the Avisa BreathTest, an innovative drug-device biomarker platform. This technology enables the exceptionally rapid identification and quantitative monitoring of virulent bacterial pathogens, activated when patients inhale or...
Where does FOGCF trade?
Avisa Diagnostics Inc. (FOGCF) trades on the Other OTC.
What sector is FOGCF in?
Avisa Diagnostics Inc. (FOGCF) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Avisa Diagnostics Inc.?
David S. Joseph is the chief executive officer of Avisa Diagnostics Inc. (FOGCF).
Where is Avisa Diagnostics Inc. headquartered?
Avisa Diagnostics Inc. is headquartered in United States.
Does FOGCF pay a dividend?
Avisa Diagnostics Inc. (FOGCF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did FOGCF go public?
Avisa Diagnostics Inc. (FOGCF) completed its initial public offering in 2021.